Back to PFE Stock Lookup

PFE Related Analyst Ratings

Apr 30, 2013 11:23 AM Pfizer (PFE) Q1 Results Might Signal Weakness at Merck (MRK)

Apr 25, 2013 05:58 PM EU Rejection of XELJANZ Will Cost Pfizer (PFE) Millions

Apr 10, 2013 11:17 AM Pfizer's (PFE) Palbociclib Has $5 Billion Potential

Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)

Mar 19, 2013 09:46 AM Brazilian Approval a Positive for Protalix (PLX) - Oppenheimer

Mar 13, 2013 10:19 AM Zoetis (ZTS) Success Could Trigger Animal Healthcare Spin-Off Bonanza

Feb 25, 2013 11:16 AM Jefferies Raises Estimates on Pfizer (PFE); Positive on Eliquis and Xeljanz Launches

Feb 7, 2013 06:52 AM Credit Suisse Reinstates Pfizer (PFE) at Neutral

Jan 28, 2013 09:15 AM iDividend: Apple (AAPL) Could Draw Investors Back in With 'Significantly' Larger Dividend - Barron's

Nov 30, 2012 06:50 AM Citi Starts Pfizer (PFE) at Buy

Nov 27, 2012 10:33 AM MKM Partners Downgrades Pfizer (PFE) to Neutral, Cites Weak Pipeline

Nov 21, 2012 08:37 AM Investors Willing to Wait on Novartis (NVS) Could Reap Dividends - Barron's

Nov 14, 2012 02:33 PM Sizing Incyte (INCY) vs. Pfizer (PFE) in Treatment for Rheumatoid Arthritis

Nov 12, 2012 08:11 AM Analysts Look Forward to Pfizer (PFE) Product Launches

Oct 5, 2012 11:06 AM MKM Partner Raises Price Target on Pfizer (PFE)

Sep 28, 2012 07:29 AM BMO Capital Starts Pfizer (PFE) at Outperform

Sep 10, 2012 08:43 AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Detrol LA Settlement Provides Small Dose of Certainty

Aug 20, 2012 11:03 AM Amarin (AMRN) NCE Status Could Happen by September 14 and Takeover Could Follow - MKM

Aug 9, 2012 01:25 PM Phizer (PFE) Will Perform Despite Difficult Second Half - Jefferies

Aug 1, 2012 01:50 PM Barclays Q2 Review on Pfizer (PFE): Will There Be Growth in 2013?

Jul 25, 2012 12:52 PM Canaccord Genuity Afternoon Coffee on PFE, ELN, and JNJ: I Just Forgot What I Was About to Say

Jul 24, 2012 10:15 AM Canaccord Genuity Morning Coffee on Dogs of the Dow: I'm Large and In Charge

Jul 18, 2012 11:13 AM Needham & Company Maintains a 'Buy' on Gilead Sciences (GILD); Q2 Preview; Quad Pill Update

Jul 16, 2012 02:27 PM Antares (ATRS) Makes New 52-Week High; Is Pfizer (PFE) Taking a Gander

Jul 13, 2012 10:33 AM Leerink Swann Maintains an 'Outperform' on Verastem (VSTM); Potential Leadership Position in FAK Inhibition

Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?

Jul 6, 2012 02:01 PM Q2 Kickoff: Alcoa (AA) Investors to Focus on LME Prices, Downstream Ops, and China

Jul 3, 2012 01:18 PM UBS Q2 Preview on U.S. Pharmaceuticals: Safe Havens in Generic, Specialty and Large-Cap

Jun 29, 2012 10:10 AM Mead Johnson (MJN) Trades Lower; Goldman Cuts Estimates, PT on New Nielsen Data

Jun 25, 2012 08:34 AM Canaccord Genuity Reiterates a 'Hold' on Protalix BioTherapeutics (PLX); Modest U.S. But Strong In Israel

Jun 12, 2012 10:19 AM Canaccord Genuity Morning Coffee on Johnson & Johnson (JNJ): Big Legal Bills To Get Bigger

Jun 8, 2012 11:02 AM Canaccord Genuity Morning Coffee on Pfizer (PFE): Woof!

May 10, 2012 01:40 PM Auriga Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Eyes on Elelyso launch in U.S.

May 2, 2012 10:14 AM UPDATE - Canaccord Genuity Downgraded Protalix BioTherapeutics (PLX) to Hold; Taking A Good Look

May 2, 2012 08:38 AM Goldman Sachs Maintains Top Rating on Pfizer (PFE), Catalysts Ahead and Possible Full Break-Up

Apr 19, 2012 09:18 AM Wells Fargo Upgrades PAREXEL International (PRXL) to Outperform; Turbo Boost

Apr 18, 2012 08:49 AM Leerink Swann Starts Puma Biotechnology (PBYI) at Outperform; Act II Has a Familiar Story Line

Apr 10, 2012 01:26 PM UBS on U.S. Pharma - Large Cap and Specialty: Q1 Preview - Off to a Good Start

Apr 10, 2012 07:43 AM ISI Group Starts Pfizer (PFE) at Buy

Apr 4, 2012 12:44 PM Canaccord Genuity on Consumer & Retail -- Health, Wellness and Lifestyle: M&A and Growth Shines at Expo

Apr 4, 2012 07:18 AM Cantor Fitzgerald Starts Celldex Therapeutics (CLDX) at Buy; Valuation Not Reflecting Depth

Apr 2, 2012 01:02 PM Citi Lifts Target on Pfizer (PFE) to $23; Says Co. Won't Break Up Pharma Unit

Mar 27, 2012 07:27 AM Pfizer (PFE) Can Go Further to Unlock Value - Goldman Sachs

Feb 23, 2012 10:06 AM Canaccord Genuity Reiterates a 'Buy' on Synta Pharma (SNTA); Ganetespid Update

Feb 3, 2012 02:04 PM Jefferies Maintains a 'Buy' on Pfizer (PFE); First Half Sweet Spot Ahead of H2'12 Pipeline Casino

Feb 2, 2012 10:53 AM Canaccord Genuity Morning Coffee on Dogs of the Dow: If You Gotta Shoot, Aim High

Jan 30, 2012 01:17 PM Q4 Preview: Pfizer (PFE) May Suffer Same Ailment as Peers: Strong Dollar Syndrome

Jan 23, 2012 03:11 PM Auriga Technical Research: Technical Takeaways: Bullish Sector Rotation Continues; Pharmaceutical ETF may be Topping

Jan 17, 2012 08:43 AM Canaccord Genuity Reiterates a 'Buy' on Synta Pharma. (SNTA) Following Meeting with Management

Jan 12, 2012 01:55 PM UBS on U.S. Pharma – Large Cap and Specialty: 4Q11 Preview: Things Still Look Interesting

Back to PFE Stock Lookup